DIA 2026 Global Annual Meeting

DIA 2026 Global Annual Meeting

arrow_back View All Dates

8:00am EDT

#600: From Breakthrough to Life: Engineered T-Cells, Patients, and the Future of Biotech 114

9:15am EDT

#601 IT: Faro Health Innovation Theater: Digital Protocols in Action - Enabling End-to-End Automation in Clinical Development Innovation Theater 1 #602 IT: PhaseV Trials Innovation Theater: From Protocol to Submission - The Real-World Impact of AI in Clinical Operations Innovation Theater 2

10:15am EDT

#603: From Guidance to Practice: Regulatory and Stakeholder Views on Evaluating Risk Minimization Measures 118AB #603.1: Case Studies on AI-Enabled and Analytical Practices and Solutions Reducing Site and Participant Burden in Clinical Trials 108A #607: Preparing for the Future: From EU Legislative Reform to Digital Transformation and AI-Driven Efficiencies 115AB #606: Enhancing Clinical Trial Oversight: Using Statistical Outlier Detection with Generative AI for Protocol Deviation Analysis 107AB #601: Inside the Investor’s Mind: How Today’s Biotech Investors Choose Where to Place Their Bets 103A #614: Indonesia Town Hall 2026 112AB #613: FDA Rare Disease Town Hall 201AB #616: How to Accelerate Utilization of Decentralized Clinical Trial: What are Issues to Perform Decentralized Clinical Trial? 117

11:30am EDT

#617 POS: Professional Poster Session III Exchange

12:30pm EDT

#620 RT: Roundtable Discussion: Can You Complete Your Submission in 10 weeks? Zone B #621 RT: Roundtable Discussion: International Regulatory Cooperation with the African Medicines Agency Zone A

1:45pm EDT

#622: Pharmacovigilance to Strengthen Vaccine Confidence and Address Hesitancy: Lessons from Brazil and Beyond 118AB #624: Optimizing Protocol Data Collection to Reduce Site and Patient Participation Burden 108B #626: Navigating the Regulatory Labyrinth: How Well Do Language Models Read the Fine Print? 107AB #628: Beyond the Keyboard: Elevating Regulatory Writing with a Business Mindset 105AB #630: Streamlining Regulatory Frameworks for Complex Generic Development: Global Extractables and Leachables Harmonization 112AB #629: Inside the Biotech Breakthroughs: How Investors and Founders Build Winning Companies 103A #632: Program Manager: Jack of All Trades, Master of None? 203AB #633: Advancing Biosimilar Development: The EU Tailored Clinical Approach and Global Harmonization Efforts 118C #635: MHRA Town Hall 119AB #634: Access Unlocked: Collaborative Strategies for Navigating Regulatory and Payor Landscapes 115AB #637: Destigmatizing 483 Observations 117 #638: Real World Evidence Throughout the Product Life Cycle: Case Studies and Real-Life Examples 116

3:00pm EDT

#629.2 RT: Roundtable Discussion: Insights Regarding Implementation of the ASAP Process TBD Roundtable Discussion: Building AI Governance Frameworks: Classification, Validation and Regulatory Alignment in Life Sciences TBD

4:00pm EDT

#643: Utilizing Signal Detection Methodologies: A Toolkit for Diverse Product Types 118AB #645: Clinical Trial Experience Surveys: Sponsor Wide Implementation Across Countries and Therapy Areas 108B #644: 50,000 Participants, Two Countries, One DCT: Oversight That Worked 108A #648: Medical Affairs: Drivers of Scientific Impact and Strategic Value in Healthcare 105AB #652: Anvisa Townhall - From Backlogs to Breakthroughs: Building a Smarter Regulatory Future 107AB #656: Singapore Town Hall 112AB #658: Navigating the Rules of Innovation: Regulatory Expectations for Generative AI Use Cases 117 #659: Real World Evidence in Regulatory Decision-Making: Challenges, Innovations, and Impact 203AB #657: Great Science Isn’t Enough: Building Value Early in Emerging Biotech 103A

DIA 2026 Global Annual Meeting

Register to attend